Clinical Trial Update: Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies

View source ↗

Summary

The document reports the completion and update of a clinical trial evaluating loratadine for G-CSF–induced bone pain in patients with leukemia or lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• Loratadine (Loratadine)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Leukemia, Lymphoma | Status: COMPLETED